+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurovascular Intervention Devices Market by Product Type, Indication, End User, Procedure Type - Global Forecast to 2030- Product Image
Neurovascular Intervention Devices Market by Product Type, Indication, End User, Procedure Type - Global Forecast to 2030- Product Image
Sale

Neurovascular Intervention Devices Market by Product Type, Indication, End User, Procedure Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674201
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurovascular Intervention Devices Market grew from USD 4.25 billion in 2024 to USD 4.53 billion in 2025. It is expected to continue growing at a CAGR of 6.52%, reaching USD 6.21 billion by 2030.

Navigating the Evolving Neurovascular Device Landscape

The neurovascular intervention devices market is undergoing rapid transformation driven by technological breakthroughs, shifting regulatory landscapes and evolving clinical needs. This executive summary distills the most pertinent trends shaping the future of treatments for conditions such as aneurysms, arteriovenous malformations and strokes. It outlines the macroeconomic forces at play, the policy changes influencing device accessibility, and the innovations unlocking new therapeutic pathways. As healthcare providers strive to improve patient outcomes and reduce procedural risks, industry stakeholders must remain agile and well-informed. This introduction sets the stage for an in-depth exploration of the critical market drivers, the emerging therapeutic modalities, and the strategic considerations that will define success in the years ahead.

By framing the discussion around key market segments, regional dynamics and competitive developments, this section prepares decision-makers to navigate complexities with clarity and confidence. The subsequent chapters will deliver actionable insights, supporting organizations in aligning product development, regulatory strategy and go-to-market approaches to the evolving demands of clinicians and patients. With this foundation, leaders can chart a course toward sustainable growth and clinical excellence.

Emerging Innovations Redefining Treatment Paradigms

Innovation and convergence are reshaping how neurovascular conditions are diagnosed, treated and managed. Advanced imaging modalities integrated with real-time analytics are enabling precise procedural planning, while devices featuring novel materials and delivery mechanisms are expanding treatment options. The rise of flow diversion strategies, combined with next-generation embolic agents, illustrates a shift toward minimally invasive therapies that reduce patient recovery times and enhance efficacy. Meanwhile, digital health platforms and artificial intelligence are accelerating the transition from reactive interventions to predictive risk assessments.

These transformative shifts are also reflected in evolving clinical guidelines, which increasingly endorse tailored treatment pathways based on patient-specific anatomical and hemodynamic profiles. Reimbursement frameworks are adapting, prioritizing value-based care models that reward outcomes rather than volume. As stakeholders embrace these changes, collaboration across device manufacturers, healthcare providers and regulatory bodies becomes imperative. The collective focus on safety, performance and cost-effectiveness is driving cross-disciplinary initiatives to standardize best practices, optimize procedural protocols and accelerate device approvals, ultimately elevating the standard of care for neurovascular patients worldwide.

Navigating Supply Chain Dynamics Amid Tariff Shifts

The imposition of tariff adjustments in 2025 has heightened cost pressures on manufacturers and distributors of neurovascular intervention devices. Products imported into the United States, which historically relied on components sourced from international suppliers, are now subject to higher duties that impact supply chain economics and pricing strategies. This shift mandates a recalibration of procurement models and compels organizations to evaluate nearshoring or alternative sourcing arrangements to mitigate margin erosion.

Beyond cost considerations, tariff changes are influencing strategic partnerships and mergers as companies seek to maintain competitive pricing without compromising on quality or innovation. Firms that invest in local manufacturing capabilities and optimize production efficiencies stand to preserve their market share and sustain investment in research and development. Meanwhile, healthcare providers are negotiating with vendors to manage unit costs and ensure uninterrupted access to critical intervention devices. The collective response to these tariffs will reverberate across the industry, underscoring the need for robust risk management and proactive engagement with policy stakeholders to navigate the evolving trade environment.

Unraveling Market Segments for Strategic Focus

A multifaceted approach to market segmentation reveals how diverse device categories and clinical applications are shaping demand patterns. Within the product type dimension, analysis spans embolic agents, flow diverters, microcatheters, neurovascular coils, stents and thrombectomy devices, with detailed examination of subcategories such as liquid embolics and particulate embolics, pipeline embolization systems versus surpass flow diverters, hydrophilic coated against polymer coated microcatheters, detachable and pushable coils, balloon mounted and self-expanding stents alongside aspiration devices and stent retrievers. Considering clinical indications, the market addresses aneurysm repair, arteriovenous malformation correction and stroke intervention, each requiring distinct device characteristics to optimize safety and efficacy.

End users range from ambulatory centers delivering outpatient procedures to specialized clinics and large hospitals equipped for complex interventions, highlighting the need for adaptable device platforms suited to diverse facility capabilities. Finally, procedural segmentation-encompassing embolization, flow diversion and thrombectomy-illuminates the interplay between clinical protocols and device innovation. Together, these insights enable stakeholders to align product development, commercialization strategies and clinician education programs with the nuanced demands of each segment, ensuring targeted investments yield maximal clinical and economic impact.

Decoding Regional Trends and Market Drivers

Regional dynamics play a pivotal role in shaping the competitive landscape and guiding market entry priorities. In the Americas, established reimbursement frameworks and widespread adoption of advanced interventional techniques drive robust demand, with major healthcare systems continuously investing in next-generation devices. Transitioning to Europe, Middle East & Africa, a mosaic of regulatory environments and reimbursement policies presents both challenges and opportunities; countries in Western Europe showcase rapid uptake of novel technologies, while emerging markets in the Middle East and Africa are increasingly prioritizing capacity building and infrastructure development to expand access to life-saving procedures.

Turning to the Asia-Pacific region, rapid economic growth, expanding healthcare budgets and rising incidence of neurovascular conditions converge to create a high-growth environment. Governments across the region are implementing reforms to improve regulatory efficiencies and enhance public-private partnerships, fostering innovation and accelerating device approvals. Recognizing these varied regional drivers empowers manufacturers and distributors to tailor market strategies, forge strategic alliances and optimize resource allocation in alignment with localized clinical needs and policy landscapes.

Profiling Industry Leaders and Innovation Drivers

Leading companies in the neurovascular intervention devices space are distinguished by their robust pipelines, strategic partnerships and commitment to clinical evidence generation. Industry frontrunners are enhancing product portfolios through targeted acquisitions of early-stage technology developers and collaborations with academic research centers. This proactive approach accelerates the translation of laboratory breakthroughs into commercial devices that address unmet clinical needs.

Moreover, top performers are deepening engagements with key opinion leaders to validate device performance in real-world settings, leveraging multicenter clinical studies to obtain compelling data on safety and long-term outcomes. Investments in digital solutions, such as procedure planning software and remote monitoring platforms, complement core device offerings and reinforce competitive differentiation. As market consolidation continues, companies that balance organic innovation with strategic M&A, while maintaining a clear regulatory and reimbursement roadmap, will secure leadership positions and set new benchmarks for clinical excellence.

Strategic Imperatives for Market Leadership

To thrive in the evolving neurovascular market, industry leaders must prioritize strategic initiatives that bridge technological innovation with operational efficiency. First, fostering integrated R&D ecosystems by collaborating with academic institutions and contract research organizations will expedite device development and regulatory approvals. Concurrently, enhancing supply chain resilience through geographically diversified manufacturing and lean inventory practices will mitigate cost volatility and ensure continuity of device availability.

Equally important is the establishment of dynamic reimbursement strategies that engage payers early in the clinical validation process, securing reimbursement codes that accurately reflect device value. Cultivating targeted education programs for interventionalists and support staff will drive procedural adoption and optimize clinical outcomes. Finally, embracing digital transformation-through AI-enabled imaging analytics and cloud-based procedure planning-will position organizations at the forefront of next-generation care delivery, unlocking new revenue streams and reinforcing market leadership.

Robust Research Framework Underpinning Insights

This analysis draws on a rigorous mixed-methodology approach combining primary interviews with leading clinicians, hospital procurement specialists and device manufacturers, alongside comprehensive secondary research encompassing peer-reviewed journals, regulatory databases and corporate filings. Clinical trial registries and real-world evidence repositories inform assessments of device performance, safety and long-term efficacy. Market dynamics are further evaluated through detailed case studies and supply chain analyses, capturing procurement structures and pricing frameworks across geographies.

Data synthesis follows a structured validation process to reconcile divergent estimates and ensure consistency. Segmentation frameworks are defined by clinical, procedural and end-user parameters, allowing for granular insights into demand drivers and adoption patterns. Regulatory landscapes are mapped through comparative policy analysis, highlighting approval pathways and reimbursement criteria. This methodology ensures that reported findings are grounded in empirical evidence, delivering actionable intelligence to inform strategic decision-making.

Consolidating Insights for Future Growth

The neurovascular intervention devices market stands at a crossroads of innovation, policy evolution and shifting clinical paradigms. Stakeholders equipped with a deep understanding of segmentation nuances, regional dynamics and competitive positioning are best prepared to seize emerging opportunities. From pioneering device platforms in flow diversion to expanding thrombolysis capabilities, the path forward demands agility, collaboration and a relentless focus on patient outcomes.

As the landscape continues to evolve, those who integrate strategic foresight with operational excellence will not only navigate challenges such as tariff pressures and regulatory complexities but also catalyze breakthroughs that redefine standards of care. By leveraging the insights outlined in this summary, industry participants can align investments, refine go-to-market plans and foster partnerships that sustain growth and advance clinical practice.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Embolic Agents
      • Liquid Embolics
      • Particulate Embolics
    • Flow Diverters
      • Pipeline Embolization Device
      • Surpass Flow Diverter
    • Microcatheters
      • Hydrophilic Coated
      • Polymer Coated
    • Neurovascular Coils
      • Detachable Coils
      • Pushable Coils
    • Stents
      • Balloon Mounted
      • Self Expanding
    • Thrombectomy Devices
      • Aspiration Devices
      • Stent Retriever
  • Indication
    • Aneurysm
    • Arteriovenous Malformation
    • Stroke
  • End User
    • Ambulatory Centers
    • Clinics
    • Hospitals
  • Procedure Type
    • Embolization
    • Flow Diversion
    • Thrombectomy
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Stryker Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Becton, Dickinson and Company
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Kaneka Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurovascular Intervention Devices Market, by Product Type
8.1. Introduction
8.2. Embolic Agents
8.2.1. Liquid Embolics
8.2.2. Particulate Embolics
8.3. Flow Diverters
8.3.1. Pipeline Embolization Device
8.3.2. Surpass Flow Diverter
8.4. Microcatheters
8.4.1. Hydrophilic Coated
8.4.2. Polymer Coated
8.5. Neurovascular Coils
8.5.1. Detachable Coils
8.5.2. Pushable Coils
8.6. Stents
8.6.1. Balloon Mounted
8.6.2. Self Expanding
8.7. Thrombectomy Devices
8.7.1. Aspiration Devices
8.7.2. Stent Retriever
9. Neurovascular Intervention Devices Market, by Indication
9.1. Introduction
9.2. Aneurysm
9.3. Arteriovenous Malformation
9.4. Stroke
10. Neurovascular Intervention Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Hospitals
11. Neurovascular Intervention Devices Market, by Procedure Type
11.1. Introduction
11.2. Embolization
11.3. Flow Diversion
11.4. Thrombectomy
12. Americas Neurovascular Intervention Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurovascular Intervention Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurovascular Intervention Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Stryker Corporation
15.3.2. Medtronic plc
15.3.3. Johnson & Johnson
15.3.4. Penumbra, Inc.
15.3.5. Boston Scientific Corporation
15.3.6. Terumo Corporation
15.3.7. Becton, Dickinson and Company
15.3.8. MicroPort Scientific Corporation
15.3.9. MicroVention, Inc.
15.3.10. Kaneka Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET MULTI-CURRENCY
FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PIPELINE EMBOLIZATION DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SURPASS FLOW DIVERTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DETACHABLE COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PUSHABLE COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON MOUNTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 67. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 68. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 69. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 70. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 71. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 72. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 82. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 129. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 133. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 138. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 139. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 143. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 158. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 159. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 160. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 161. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 162. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 163. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 173. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 213. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 228. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 229. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 230. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 231. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 232. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 233. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 238. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 239. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 243. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 269. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 271. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 273. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 278. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 279. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 280. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 281. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 283. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

The companies profiled in this Neurovascular Intervention Devices market report include:
  • Stryker Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Becton, Dickinson and Company
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Kaneka Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.21 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neurovascular Devices Market by Product Type, Indication, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Neurovascular Devices Market by Product Type, Indication, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Neurovascular Devices Market Report by Product, End User, and Region 2024-2032 - Product Image

Neurovascular Devices Market Report by Product, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report - Product Image

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Neurovascular Neurology Devices Market by Product, Indication, Technology, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Neurovascular Neurology Devices Market by Product, Indication, Technology, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Neurothrombectomy Devices - Global Strategic Business Report - Product Image

Neurothrombectomy Devices - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From

About the Neurovascular Intervention Device Market

The Neurovascular Intervention Device market is a subset of the Neurology Devices market, which includes a range of medical devices used to diagnose and treat neurological conditions. Neurovascular Intervention Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to access the brain and other parts of the nervous system, and to deliver treatments such as stents, balloons, and coils. The Neurovascular Intervention Device market is highly competitive, with a range of companies offering a variety of products. Some of the major players in the market include Medtronic, Stryker, Johnson & Johnson, Boston Scientific, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.